Alligator Bioscience AB (STU:7AL) Operating Cash Flow per Share : €-0.04 (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alligator Bioscience AB Operating Cash Flow per Share?

Alligator Bioscience AB's operating cash flow per share for the three months ended in Mar. 2024 was €-0.01. Alligator Bioscience AB's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Alligator Bioscience AB's Operating Cash Flow per Share or its related term are showing as below:

STU:7AL' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -59.5 Med: -9.7 Max: 29.4
Current: 29.4

During the past 10 years, Alligator Bioscience AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.40% per year. The lowest was -59.50% per year. And the median was -9.70% per year.

STU:7AL's 3-Year OCF Growth Rate is ranked better than
79.03% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs STU:7AL: 29.40

Alligator Bioscience AB Operating Cash Flow per Share Historical Data

The historical data trend for Alligator Bioscience AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Operating Cash Flow per Share Chart

Alligator Bioscience AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.13

-0.12

-0.08

-0.07

-0.04

Alligator Bioscience AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.02	-0.01	-0.01	-0.01	-0.01

Competitive Comparison of Alligator Bioscience AB's Operating Cash Flow per Share

For the Biotechnology subindustry, Alligator Bioscience AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alligator Bioscience AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's Price-to-Operating-Cash-Flow falls into.

Alligator Bioscience AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Alligator Bioscience AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-16.922	/	448.490
	=	-0.04

Alligator Bioscience AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-7.316	/	657.954
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04

Alligator Bioscience AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB (STU:7AL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (STU:7AL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 7AL:Germany

Address

Scheelevagen 2, Medicon Village, Lund, SWE, 223 81

Website

http://www.alligatorbioscience.com

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (STU:7AL) Headlines

No Headlines